A Phase II/III Study of NPC-09 (N-acetylneuraminic acid) in Patients with GNE Myopathy (GNEM)

Trial Profile

A Phase II/III Study of NPC-09 (N-acetylneuraminic acid) in Patients with GNE Myopathy (GNEM)

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 26 Aug 2016

At a glance

  • Drugs Aceneuramic acid (Primary)
  • Indications Nonaka distal myopathy
  • Focus Therapeutic Use
  • Sponsors Nobelpharma
  • Most Recent Events

    • 24 Aug 2016 Status changed from recruiting to active, no longer recruiting.
    • 08 Aug 2016 Planned End Date changed from 31 Mar 2017 to 30 Sep 2017.
    • 20 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top